Consequences of Pancreatitis

Mortality and Survival Outcomes

The mortality rate for acute pancreatitis ranges from 10-15% overall, but can reach 35-70% in severe cases with infected necrosis and organ failure, with persistent organ failure being the strongest predictor of mortality 1, 2
The American College of Gastroenterology recommends considering the severity of disease and complications when assessing mortality risk, with necrotizing pancreatitis having a 30-40% mortality rate, sterile pancreatic necrosis having a 0-11% mortality rate, and infected pancreatic necrosis having a 40% average mortality rate 2
The mortality rate for infected necrosis with organ failure is 35.2%, which is the highest risk scenario, while the mortality rate for infected necrosis without organ failure is 1.4% 1, 2

Acute fluid collections develop in 30-50% of patients with severe pancreatitis, and having three or more collections significantly increases the risk of complications and death, according to the British Society of Gastroenterology 3, 4
Pseudocysts can form in patients with severe pancreatitis, indicated by epigastric mass and vomiting, and require drainage or surgical intervention, as recommended by the European Society of Gastrointestinal Endoscopy 3, 4, 5

Cardiovascular, respiratory, and renal failure are the most common organ failures associated with increased mortality in acute pancreatitis, with respiratory failure manifesting as pneumonic consolidation, pleural effusions, and acute respiratory distress syndrome (ARDS), according to the Society of Critical Care Medicine 2, 3, 4, 5
The American Heart Association recommends monitoring for cardiovascular complications, including shock and hemodynamic instability, in patients with acute pancreatitis 2

Infection of pancreatic necrosis typically occurs 7-14 days after disease onset and represents a critical turning point, with clinical indicators including sudden high fever, increasing leucocyte and platelet counts, and deranged clotting parameters, as recommended by the Infectious Diseases Society of America 3, 4, 5, 6

Elderly patients with comorbid conditions, postoperative acute pancreatitis patients, and patients with persistent SIRS are at higher risk of mortality, with mortality rates of 25.4% versus 8% with transient SIRS, according to the American Geriatrics Society 2
Patients with extent of necrosis >30% are also at higher risk of mortality, as recommended by the European Society of Gastrointestinal Endoscopy 6, 2

Elevated early concentrations of secretory phospholipase A₂‑II, interleukin‑1β, and interleukin‑6, followed by increased soluble IL‑2 receptor (a lymphocyte activation marker), are directly associated with the development of multiple organ failure in patients with acute pancreatitis. 7

Persistent SIRS after the onset of acute pancreatitis signals a high risk of progression to organ failure, including ARDS. 8

Patients who exhibit persistent SIRS have an in‑hospital mortality rate of approximately 25 % (25.4 %), whereas those with transient SIRS have a markedly lower mortality of about 8 %. [8][9]